Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, what timetable NHS England has set for developing a commissioning policy for the Everolimus drug.

NHS England is currently developingtwo policies for the provision of Everolimus – one for the Tuberous Sclerosis forComplex Related Renal Angiomyolipoma andone for SubependymalGiant Cell Astrocytoma (SEGA). This was communicated to the National Health Service in a Specialised Services Circular on 2 July 2015.

These two policies will both be considered as in-year items for the specialised services work programme for 2015/16- however, a timetable for publication has not yet been agreed.